The Innovation Medicines Accelerator (IMA) seeks to accelerate the translation of Stanford research discoveries into new medicines while expanding our knowledge of human biology.
How can the IMA advance your research?
The IMA is running a series of calls for proposals for Stanford faculty to access funding, platforms, and in-kind translational resources.
What is Stanford's Innovative Medicines Accelerator?
The newly created Innovative Medicines Accelerator (IMA) is envisioned to overcome obstacles in developing medicines for everything from deadly diseases like cancer and COVID-19 to rare disorders overlooked by most pharmaceutical companies.Read More